Green Therapeutics LLC and Meridian Companies LLC Commence Formal Legal Action Against Australis Capital Inc. and Certain of its Affiliates for Breach of Contract

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Green Therapeutics LLC and Meridian Companies LLC Commence Formal Legal Action Against Australis Capital Inc. and Certain of its Affiliates for Breach of Contract

Canada NewsWire

TORONTO, June 30, 2020 /CNW/ - Green Therapeutics LLC and Meridian Companies LLC (together referred to herein as the "Plaintiffs") announced today that they commenced formal legal action against Australis Capital Inc. ("Australis"), Australis Prosper LLC, Australis Terrain LLC and Australis Perennial LLC (together with Australis referred to herein as "Defendants") (CSE: AUSA) on April 8, 2020 for various breaches of the contracts described in Australis' press release dated May 21, 2019 (the "Contracts") pursuant to which the Plaintiffs transferred certain cannabis licenses, brands, 8.9 acres of land in North Las Vegas, Nevada (the " Property"), and other intellectual property, assets, and rights (collectively, the "Transferred Assets") to the Defendants in exchange for common shares of Australis and other promises and rights. Together the Plaintiffs are one of Australis' largest shareholders, together holding 11,413,376 common shares (being approximately 6.7% of the issued and outstanding shares).

The Plaintiffs allege that the transactions contemplated by the Contracts were predicated on Australis establishing its flagship cultivation and manufacturing facility (the "Manufacturing Facility") with Green Therapeutics' experienced operational team and the Transferred Assets. 

Australis has decided to change its business from cannabis brand development, intellectual property, technology, cultivation and manufacturing to ATM, payments, and merchant services.  Construction of the Manufacturing Facility is not part of Australis' business plans, and Australis has announced that it intends to sell the Property and use the proceeds to purchase Passport Technology Inc. (or alternatively transfer the property in connection with such transaction), a company majority owned and controlled by a director of Australis (see the Australis' press release dated June 25, 2020).

Pursuant to the legal action the Plaintiffs are seeking injunctive relief, rescission of the Contracts and damages.

SOURCE Green Therapeutics LLC

Cision View original content: http://www.newswire.ca/en/releases/archive/June2020/30/c9638.html

Copyright CNW Group 2020

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).